A recent study published in JAMA reveals that adults with prediabetes who engaged in intensive lifestyle coaching were significantly less likely to develop multiple chronic diseases over 21 years compared to those taking metformin. The findings suggest that lifestyle interventio…
A recent study presented at the American Heart Association's Scientific Sessions 2026 indicates that medically tailored meals can enhance health outcomes for adults with type 2 di…
A recent study has highlighted a concerning correlation between early-onset Type 2 diabetes and neurodivergent conditions such as ADHD and autism in youth. Researchers found that…
A recent pooled analysis of five clinical trials has highlighted the potential benefits of time-restricted eating for weight loss. The study found that participants who limited th…
A recent clinical trial has found that berberine, a natural compound, can reduce blood sugar levels comparably to metformin, the standard treatment for Type 2 diabetes. The study,…
This article explores the critical distinction between treating diseases and facilitating true healing in patients. It emphasizes that while medical interventions can effectively…
Viome Life Sciences has acquired Circulate Health, merging its molecular diagnostics and precision nutrition capabilities with Circulate's therapeutic plasma exchange services. Th…
A recent qualitative study explores the experiences of primary care physicians (PCPs) regarding nutrition counseling, revealing significant gaps in training and practical challeng…
An FDA advisory committee has voted to recommend broader access to six peptides, potentially allowing licensed compounding pharmacies to prepare them for valid prescriptions. This…
The FDA is reviewing seven unapproved peptides that have gained popularity for their purported health benefits, including weight loss and chronic disease management. The review co…